HeartSciences CEO to Participate in the Benzinga All Access Event on July 15th

Southlake, Texas, July 13, 2022 (GLOBE NEWSWIRE) — HeartSciences (NASDAQ: HSCS; HSCSW) (“Company”), a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to significantly expand and improve an ECG’s clinical usefulness, today announced that Andrew Simpson, CEO, and Chairman of HeartSciences, will be participating in the Benzinga All Access event taking place on July 15, 2022.

Mr. Simpson is scheduled to present on Friday, July 15, 2022, at 10:00 A.M. Eastern Time.

The event will be broadcast live and can be viewed https://www.youtube.com/watch?v=JuM_q3iRTeM&feature=youtu.be. An archived recording of the presentation will be available on the investor relations section of the Company’s website at https://ir.heartsciences.com/.

Contacts

MEDIA RELATIONS

Gene Gephart
Director of Marketing
+1-682-244-2578 (US)

INVESTOR CONTACT

Vivian Cervantes
Gilmartin Group